Citation Tools

other Versions

PDF
Randomised controlled trial
Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes

Download to a citation manager

Cite this article as:
Campbell-Scherer D
Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes